{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:22:38Z","timestamp":1772119358259,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00467-025-06869-0","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T23:26:19Z","timestamp":1753485979000},"page":"3755-3760","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ferric carboxymaltose use in pediatric kidney transplant recipients with iron deficiency"],"prefix":"10.1007","volume":"40","author":[{"given":"Diletta Domenica","family":"Torres","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi Antonio","family":"Moscogiuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Font\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenza","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marida","family":"Martino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Santangelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4224-636X","authenticated-orcid":false,"given":"Mario","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,26]]},"reference":[{"key":"6869_CR1","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1053\/ajkd.2002.36910","volume":"40","author":"PD Yorgin","year":"2002","unstructured":"Yorgin PD, Belson A, Sanchez J, Al Uzri AY, Sarwal M, Bloch DA, Oehlert J, Salvatierra O, Alexander SR (2002) Unexpectedly high prevalence of posttransplant anemia in pediatric and young adult renal transplant recipients. Am J Kidney Dis 40:1306\u20131318","journal-title":"Am J Kidney Dis"},{"key":"6869_CR2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/kisup.2012.37","volume":"2","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group","year":"2012","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group (2012) KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl 2:279\u2013335","journal-title":"Kidney Int Suppl"},{"key":"6869_CR3","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s00467-011-2036-1","volume":"27","author":"PJ Galutira","year":"2012","unstructured":"Galutira PJ, Del Rio M (2012) Understanding renal post-transplantation anemia in the pediatric population. Pediatr Nephrol 27:1079\u20131085","journal-title":"Pediatr Nephrol"},{"key":"6869_CR4","first-page":"9","volume":"7","author":"CI Macdougall","year":"2013","unstructured":"Macdougall CI, Geisser P (2013) Use of intravenous iron supplementation in chronic kidney disease an update. Iran J Kidney Dis 7:9\u201322","journal-title":"Iran J Kidney Dis"},{"key":"6869_CR5","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/ki.2012.270","volume":"82","author":"TB Dr\u00fceke","year":"2012","unstructured":"Dr\u00fceke TB, Parfrey PS (2012) Summary of the KDIGO guideline on anemia and comment: reading between the (guide)line(s). Kidney Int 82:952\u2013960","journal-title":"Kidney Int"},{"key":"6869_CR6","doi-asserted-by":"publisher","first-page":"3781","DOI":"10.1007\/s00431-022-04582-w","volume":"181","author":"A Aksan","year":"2022","unstructured":"Aksan A, Zepp F, Anand S, Stein J (2022) Intravenous ferric carboxymaltose for the management of iron deficiency and iron deficiency anaemia in children and adolescents: a review. Eur J Pediatr 181:3781\u20133793","journal-title":"Eur J Pediatr"},{"key":"6869_CR7","doi-asserted-by":"publisher","first-page":"e13787","DOI":"10.1111\/petr.13787","volume":"24","author":"F Iorember","year":"2020","unstructured":"Iorember F, Aviles D, Bamgbola O (2020) Impact of immediate post-transplant parenteral iron therapy on the prevalence of anemia and short-term allograft function in a cohort of pediatric and adolescent renal transplant recipients. Pediatr Transplant 24:e13787","journal-title":"Pediatr Transplant"},{"key":"6869_CR8","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1007\/s00431-017-2995-8","volume":"176","author":"MLN Tan","year":"2017","unstructured":"Tan MLN, Windscheif PM, Thornton G, Gaynor E, Rodrigues A, Howarth L (2017) Retrospective review of effectiveness and safety of intravenous ferric carboxymaltose given to children with iron deficiency anaemia in one UK tertiary centre. Eur J Pediatr 176:1419\u20131423","journal-title":"Eur J Pediatr"},{"key":"6869_CR9","doi-asserted-by":"publisher","first-page":"e124486","DOI":"10.1172\/jci.insight.124486","volume":"3","author":"M Wolf","year":"2018","unstructured":"Wolf M, Chertow GM, Macdougall IC, Kaper R, Krop J, Strauss W (2018) Randomized trial of intravenous iron-induced hypophosphatemia. JCI Insight 3:e124486","journal-title":"JCI Insight"},{"key":"6869_CR10","doi-asserted-by":"crossref","unstructured":"Klein K, Asaad S, Econs M, Rubin JE (2018) Severe FGF23-based hypophosphataemic osteomalacia due to ferric carboxymaltose administration. BMJ Case Rep 2018:bcr-2017\u2013222851","DOI":"10.1136\/bcr-2017-222851"},{"key":"6869_CR11","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1111\/bcp.14643","volume":"87","author":"B Schaefer","year":"2021","unstructured":"Schaefer B, Tobiasch M, Viveiros A, Tilg H, Kennedy NA, Wolf M, Zoller H (2021) Hypophosphataemia after treatment of iron deficiency with intravenous ferric carboxymaltose or iron isomaltoside-a systematic review and meta-analysis. Br J Clin Pharmacol 87:2256\u20132273","journal-title":"Br J Clin Pharmacol"},{"key":"6869_CR12","doi-asserted-by":"publisher","first-page":"E215","DOI":"10.1002\/ajh.26165","volume":"96","author":"SE Kirk","year":"2021","unstructured":"Kirk SE, Scheurer ME, Bernhardt MB, Mahoney DH, Powers JM (2021) Phosphorus levels in children treated with intravenous ferric carboxymaltose. Am J Hematol 96:E215\u2013E218","journal-title":"Am J Hematol"},{"key":"6869_CR13","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1111\/apa.15178","volume":"109","author":"A Posod","year":"2020","unstructured":"Posod A, Schaefer B, Mueller T, Zoller H, Kiechl-Kohlendorfer U (2020) Hypophosphatemia in children treated with ferric carboxymaltose. Acta Paediatr 109:1491\u20131492","journal-title":"Acta Paediatr"},{"key":"6869_CR14","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/1471-230X-14-184","volume":"14","author":"MW Laass","year":"2014","unstructured":"Laass MW, Straub S, Chainey S, Virgin G, Cushway T (2014) Effectiveness and safety of ferric carboxymaltose treatment in children and adolescents with inflammatory bowel disease and other gastrointestinal diseases. BMC Gastroenterol 14:184","journal-title":"BMC Gastroenterol"},{"key":"6869_CR15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.21037\/tp.2019.01.01","volume":"8","author":"N Carman","year":"2019","unstructured":"Carman N, Muir R, Lewindon P (2019) Ferric carboxymaltose in the treatment of iron deficiency in pediatric inflammatory bowel disease. Transl Pediatr 8:28\u201334","journal-title":"Transl Pediatr"},{"key":"6869_CR16","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1111\/bcp.13493","volume":"84","author":"M Papadopoulos","year":"2018","unstructured":"Papadopoulos M, Patel D, Korologou-Linden R, Goto E (2018) Safety and efficacy of parenteral iron in children with inflammatory bowel disease. Br J Clin Pharmacol 84:694\u2013699","journal-title":"Br J Clin Pharmacol"},{"key":"6869_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.967233","volume":"10","author":"P Garcia-Ortega","year":"2022","unstructured":"Garcia-Ortega P, Jimenez-Lozano I, Cruz \u00c1, Polo AF, Lopez M, Ariceta G (2022) Safety and effectiveness of ferric carboxymaltose intravenous therapy in pediatric patients with chronic kidney disease. Front Pediatr 10:967233","journal-title":"Front Pediatr"},{"key":"6869_CR18","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1007\/s00467-022-05743-7","volume":"38","author":"I Guzzo","year":"2023","unstructured":"Guzzo I, Atkinson MA (2023) Anemia after kidney transplantation. Pediatr Nephrol 38:3265\u20133273","journal-title":"Pediatr Nephrol"},{"key":"6869_CR19","unstructured":"(2021) Ferinject (ferric carboxymaltose) summary of product characteristics. https:\/\/www.medicines.org.uk\/emc\/product\/5910\/smpc. Accessed May 2022"},{"key":"6869_CR20","unstructured":"(2022) Injectafer prescribing information. https:\/\/injectafer.com\/. Accessed May 2022"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-06869-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-025-06869-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-025-06869-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T09:24:43Z","timestamp":1761211483000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-025-06869-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,26]]},"references-count":20,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["6869"],"URL":"https:\/\/doi.org\/10.1007\/s00467-025-06869-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5052408\/v1","asserted-by":"object"}]},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,26]]},"assertion":[{"value":"10 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}